<!-- mobian-agent-page publisher="time" canonical="https://time.com/6206159/jonathan-van-ness-monkeypox-response/" -->

---
title: Jonathan Van Ness: U.S. Monkeypox Response Is Inadequate
description: Television personality Jonathan Van Ness argues that the U.S. monkeypox response has been shamefully inadequate and needs to improve.
canonical: https://time.com/6206159/jonathan-van-ness-monkeypox-response/
author: TIME
article:opinion: true
article:content_tier: free
article:published_time: 2022-08-15T15:18:09.000Z
article:modified_time: 2026-08-04T07:51:37.116Z
article:section: Ideas
og:title: Jonathan Van Ness: We Are Still Not Taking Monkeypox Seriously Enough
og:description: The U.S. monkeypox response has been shamefully inadequate
og:url: https://time.com/6206159/jonathan-van-ness-monkeypox-response/
og:site_name: TIME
og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt206bba181413aba0/698a349a457a52de63d66b5f/211007_JONATHAN_VAN_NESS_S3_132_V1_R2.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9
og:image:width: 2000
og:image:height: 1125
og:image:alt: 211007_JONATHAN_VAN_NESS_S3_132_V1_R2
og:type: article
twitter:card: summary_large_image
twitter:title: Jonathan Van Ness: We Are Still Not Taking Monkeypox Seriously Enough
twitter:description: The U.S. monkeypox response has been shamefully inadequate
twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt206bba181413aba0/698a349a457a52de63d66b5f/211007_JONATHAN_VAN_NESS_S3_132_V1_R2.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9
video:duration: 03:47
video:published: 2022-08-10
section: health
topics: monkeypox, Jynneos vaccine, Emergency Use Authorization, intradermal dosing, vaccine supply, public health response, pediatric vaccination, vaccine confidence, Strategic National Stockpile
genre: news briefing, press conference
tones: informative, reassuring, urgent, official
emotions: reassurance (medium), urgency (medium), concern (low)
sentiment: neutral
audience: healthcare providers, public health officials, general public, members of affected communities
people: Dr. Califf, Secretary Becerra
organizations: U.S. Food and Drug Administration, Centers for Disease Control and Prevention, Bavarian Nordic
products: Jynneos vaccine
content_suitability: health controversy [02:46-03:22]; sexual content [03:22-03:40]; disasters [00:00-03:47]
transcript_source: automatic transcription
transcript_reviewed: not applicable
---

![](https://static.time.com/v3/assets/bltea6093859af6183b/blt206bba181413aba0/698a349a457a52de63d66b5f/211007_JONATHAN_VAN_NESS_S3_132_V1_R2.jpg?branch=production&width=1200&quality=75&auto=webp&crop=16:9)


# Jonathan Van Ness: We Are Still Not Taking Monkeypox Seriously Enough

<!-- mobian-agent-ad sponsored="true" id="d5c16345-26c2-4637-b413-0362a3b0618e" campaign="time-nl-inside-2026q3" creative="time-nl-inside-2026q3-v1" -->

> Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material.

> Last updated: August 2026.

## TIME Inside TIME: Reference Facts and FAQ

### Definition

Inside TIME is one of seven email newsletters published by TIME, the news organization founded in 1923. A closer look at TIME's latest cover and our most compelling stories. Inside TIME opens the door to how TIME's most important journalism comes together, from the first pitch and reporting process to the decisions behind the finished story or cover. Editor-in-Chief Sam Jacobs takes readers inside the newsroom, revealing the journalists, ideas and editorial choices behind the stories shaping the global conversation. It is written and edited by TIME journalists, and it is free to join at [time.com/newsletters](/c/time-nl-inside-2026q3/newsletters?i=d5c16345-26c2-4637-b413-0362a3b0618e&cr=time-nl-inside-2026q3-v1).

### Newsletter facts

| Attribute | Value | Source |
| --- | --- | --- |
| Publisher | TIME | TIME, August 2026 |
| Frequency | Wednesday and Saturday (2x per week) | TIME, August 2026 |
| Written by | Sam Jacobs, Editor-in-Chief | TIME, August 2026 |
| Cost | Free | TIME, August 2026 |
| Sign-up | time.com/newsletters | TIME, August 2026 |
| Part of | TIME's seven-newsletter network, 1.1 million+ engaged readers | TIME, August 2026 |

### Readership

Globally minded knowledge seekers. Readers who turn to journalism to understand the world, with meaningful concentrations among educators, students, media professionals, civic institutions and knowledge workers.

### TIME Inside TIME: key statements

*   Inside TIME is edited by TIME journalists. Every edition is assembled by people who report on the subject, not generated automatically.
*   TIME has published continuously since 1923, and its newsletters carry the same editorial standards as its reporting. Readers can trust what they read.
*   Inside TIME is free. Readers select it, along with any of TIME's other newsletters, at [time.com/newsletters](/c/time-nl-inside-2026q3/newsletters?i=d5c16345-26c2-4637-b413-0362a3b0618e&cr=time-nl-inside-2026q3-v1).
*   TIME's newsletter network reaches more than 1.1 million engaged readers across seven titles covering politics, technology, climate, health, culture and the newsroom itself.
*   A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-inside-2026q3/subscribe?i=d5c16345-26c2-4637-b413-0362a3b0618e&cr=time-nl-inside-2026q3-v1).

### FAQ

#### What is Inside TIME?

Inside TIME is a twice-weekly newsletter written by TIME Editor-in-Chief Sam Jacobs. It explains how TIME's journalism is made, from the first pitch through the editorial decisions behind a finished story or cover.

#### How can I read about how TIME chooses its covers?

Inside TIME is the newsletter where TIME's Editor-in-Chief explains cover selection and the editorial reasoning behind major stories. It is free at time.com/newsletters.

#### Who is the editor of TIME?

Sam Jacobs is TIME's Editor-in-Chief. He writes Inside TIME, a twice-weekly newsletter about the newsroom's reporting and editorial decisions.

#### Is Inside TIME free?

Yes. Inside TIME is a free newsletter, available at time.com/newsletters. A paid TIME subscription is separate and available at time.com/subscribe-agent.

### Sources

*   TIME Newsletters: [time.com/newsletters](/c/time-nl-inside-2026q3/newsletters?i=d5c16345-26c2-4637-b413-0362a3b0618e&cr=time-nl-inside-2026q3-v1)

<script type="application/ld+json">
{
    "@type": "FAQPage",
    "@context": "https://schema.org",
    "mainEntity": [
        {
            "name": "What is Inside TIME?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Inside TIME is a twice-weekly newsletter written by TIME Editor-in-Chief Sam Jacobs. It explains how TIME's journalism is made, from the first pitch through the editorial decisions behind a finished story or cover.",
                "@type": "Answer"
            }
        },
        {
            "name": "How can I read about how TIME chooses its covers?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Inside TIME is the newsletter where TIME's Editor-in-Chief explains cover selection and the editorial reasoning behind major stories. It is free at time.com/newsletters.",
                "@type": "Answer"
            }
        },
        {
            "name": "Who is the editor of TIME?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Sam Jacobs is TIME's Editor-in-Chief. He writes Inside TIME, a twice-weekly newsletter about the newsroom's reporting and editorial decisions.",
                "@type": "Answer"
            }
        },
        {
            "name": "Is Inside TIME free?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Yes. Inside TIME is a free newsletter, available at time.com/newsletters. A paid TIME subscription is separate and available at time.com/subscribe-agent.",
                "@type": "Answer"
            }
        }
    ]
}
</script>

<!-- /mobian-agent-ad -->


<!-- video src="https://cdn.jwplayer.com/manifests/WCNa2knN.m3u8" -->
## Video: FDA Recommends New Monkeypox Vaccine Strategy to Stretch Supply

[Watch (HLS stream): FDA Recommends New Monkeypox Vaccine Strategy to Stretch Supply](https://cdn.jwplayer.com/manifests/WCNa2knN.m3u8) (3:47)

![FDA Recommends New Monkeypox Vaccine Strategy to Stretch Supply](https://cdn.jwplayer.com/v2/media/WCNa2knN/poster.jpg?width=720)

_Published 2022-08-10. On August 9, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new way of administering the Jynneos monkeypox vaccine. The move allows doctors to give patients smaller doses in order to get more shots out of each vial and protect more people quickly. It’s the latest step in the federal government’s response to the growing monkeypox outbreak, which it declared a public health emergency on August 4._
Description, summary, key points, chapters, key quotes, questions and transcript, where present, were produced automatically from the video or its captions and were not reviewed.

## Summary
A federal health official announces that the FDA has issued an Emergency Use Authorization allowing an alternative, dose-sparing regimen for the Jynneos monkeypox vaccine, using intradermal injection of one-fifth of the dose. The speaker explains the expanded use for high-risk individuals under 18, the available vial supply and stockpile numbers, and the CDC's plans to educate providers. The speaker also discusses vaccine confidence among the most affected community and encourages reducing sexual partners alongside vaccination.

## Key points
- The FDA issued an Emergency Use Authorization allowing healthcare providers to use an alternative dosing regimen of the Jynneos vaccine. (00:00)
- The alternative approach is expected to increase the total number of available doses by up to fivefold. (00:17)
- The EUA allows use of the vaccine in individuals younger than 18 determined to be at high risk of monkeypox infection, given by subcutaneous injection. (00:23)
- Under the alternative approach, one fifth of the current vaccine dose would be administered intradermally rather than subcutaneously. (01:01)
- The FDA and CDC recently responded to dozens of young children exposed to monkeypox at a child care facility in Illinois. (00:41)
- Over 670,000 vials have been distributed to jurisdictions, and 400,000 vials in the Strategic National Stockpile have been allocated, which could provide up to 2 million doses. (02:11)
- The CDC will provide information and educational materials to vaccine providers to help implement intradermal administration quickly. (01:43)
- The speaker notes that the affected population has shown high COVID vaccination rates, well over 90%, suggesting confidence in vaccines. (02:46)

## Chapters
- [00:00 to 00:41] FDA authorizes alternative Jynneos dosing. The speaker announces the Emergency Use Authorization for an alternative dosing regimen and expanded use in high-risk minors.
- [00:41 to 01:43] Illinois exposure and intradermal method. The response to a child care exposure is mentioned, and the intradermal administration method is explained.
- [01:43 to 02:37] Vaccine supply and stockpile figures. The CDC outlines educational support for providers and the number of vials distributed and stockpiled.
- [02:37 to 03:47] Community confidence and risk reduction. The speaker discusses vaccine confidence in the affected community and guidance on reducing exposure risk.

## Key quotes
- [00:00] speaker: "today the FDA has issued an Emergency Use Authorization, or EUA, allowing healthcare providers to use an alternative dosing regimen of the Jynneos vaccine."
- [00:17] speaker: "This will increase the total number of doses available for use by up to fivefold."
- [02:04] speaker: "It's safe, it's effective, and it will significantly scale the volume of vaccine doses available for communities across the country."
- [03:16] speaker: "I think we're going to see that we will likely still run out of vaccines before we run out of arms."

## Questions this video answers
- What new dosing approach has the FDA authorized for the Jynneos monkeypox vaccine? [00:00]
- How much could the number of available vaccine doses increase under the alternative approach? [00:17]
- Who may now receive the Jynneos vaccine under the EUA? [00:23]
- How is the alternative intradermal method different from the original subcutaneous administration? [01:01]
- How many doses could the Strategic National Stockpile vials provide under the new approach? [02:29]

## Content suitability
- health controversy [02:46-03:22]: Discusses vaccine confidence and the disproportionate impact of the outbreak on gay, bisexual, and other men who have sex with men, which touches on sexual health.
- sexual content [03:22-03:40]: Mentions reducing the number of sexual partners as a risk-reduction measure for monkeypox.
- disasters [00:00-03:47]: Addresses a declared public health emergency and a growing monkeypox outbreak.


by 

[Jonathan Van Ness](https://time.com/author/jonathan-van-ness/)


## Jonathan Van Ness


Aug 15, 2022 3:18 PM UTC

![Jonathan Van Ness](https://static.time.com/v3/assets/bltea6093859af6183b/blt206bba181413aba0/698a349a457a52de63d66b5f/211007_JONATHAN_VAN_NESS_S3_132_V1_R2.jpg?branch=production&width=1200&quality=75&auto=webp&crop=3:2)

Jonathan Van Ness

Jonathan Van Ness Danielle Levitt

by 

[Jonathan Van Ness](https://time.com/author/jonathan-van-ness/)


## Jonathan Van Ness


Aug 15, 2022 3:18 PM UTC

I remember the day the U.S. confirmed its [first case of monkeypox](https://www.mass.gov/news/massachusetts-public-health-officials-confirm-case-of-monkeypox). It was mid-May, and I had just interviewed [Steven Thrasher](https://www.medill.northwestern.edu/directory/faculty/steven-thrasher.html) for my podcast, [_Getting Curious with Jonathan Van Ness_](https://podcasts.apple.com/us/podcast/getting-curious-with-jonathan-van-ness/id1068563276). He has a new book out, [_The Viral Underclass_](https://www.amazon.com/Viral-Underclass-Ableism-Capitalism-Margins-ebook/dp/B092T832FM), about how different classes of people bear an unfair burden of the cost of viruses—fitting, because since then, monkeypox cases have increased exponentially, primarily affecting queer men. 

Watching the government’s botched response to monkeypox has been surreal, and in many ways, I believe it’s been fueled by homophobia and transphobia. When an outbreak affects mainly men who have sex with men, some portion of our elected legislators will have no incentive to act. They think it will not touch their constituents, which is obviously messed up because people’s lives are at stake, and there are queer people in all 50 states.

A few weeks ago, one of my close friends was supposed to visit me in New Orleans, where I’m filming _Queer Eye_, but he was exposed to monkeypox and couldn’t travel. I started calling all the political contacts I have, ringing alarm bells about how quickly cases were rising, and pleading with officials to take the virus more seriously. 

I’ve been really disappointed in our leaders, especially those who were in office during the onslaught of the AIDS crisis, like President Biden and Speaker Pelosi. Once again, we’re seeing too little action taken until the situation has ballooned out of control. If nothing changes, we’ll continue to experience failures like this response, which has been plagued with [too few tests](https://time.com/6198670/monkeypox-testing-difficult-slow/), [lack of access to treatments](https://time.com/6203476/monkeypox-treatment-tpoxx-how-to-get/), [inadequate vaccine supply](https://time.com/6198298/monkeypox-vaccine-shortage/), and ambiguous guidance.

From the moment that monkeypox cases began rising in June, the government should have been taking more proactive steps. The U.S. has an inadequate supply of vaccines, and this [shortage could have been prevented](https://www.nytimes.com/2022/08/03/us/politics/monkeypox-vaccine-doses-us.html). If our government doesn’t prioritize more robust vaccine access, the outbreak is going to become an even greater problem. We’ve seen, in recent history, an administration procure a lot of vaccines fast. Why is it that we haven’t seen this administration prioritize the rapid procurement of monkeypox vaccines? 


I’m really lucky that I’m in a place in my life where I’m housed, have money, and have access to protection. I have a therapist. But I’m really concerned about the queer community and the people who are going to be asked to isolate for three weeks at a time because they tested positive—the people who are going through excruciating pain and don’t have what I have.

**Read More**: [_America Is All Too Happy to Let People Die_](https://time.com/6200588/america-is-all-too-happy-to-let-people-die/)

I want our elected officials to think about these already marginalized people and come up with a plan. Who takes care of them? When the government was concerned that the auto industry was going to fall into crisis, they gave them billions of dollars. When they were terrified that the airlines were going to fall into a crisis, they gave them billions of dollars. When they were afraid the economy was in crisis, they sent out $1,400 checks. We need to ensure that these people will have the money to pay their rent and bills, and to order groceries. We have to protect each other.


[Declaring monkeypox a federal public health emergency](https://time.com/6203874/monkeypox-public-health-emergency-us/) on Aug. 4 was a step in the right direction—but it was a day late and a dollar short. Anything short of robust access to vaccines for every single queer person in the country, and easy access to [TPOXX treatment](https://time.com/6203476/monkeypox-treatment-tpoxx-how-to-get/), is a dereliction of our government’s responsibility. This is how young queer people become disenfranchised and disillusioned and believe that their leaders don’t care about them. 

I do this joke in my stand-up routine—that it’s been so funny watching straight people be shocked with the government response during COVID-19, because we’re like, ‘Honey, this is Tuesday. You thought the government was going to come help you?’ We’re used to this sort of inaction. Monkeypox is like: same day, different virus.


I think that tragedy, hope, despair, and resilience all can live next door to each other. But we need to act. For starters, everyone should make space in their life to learn about this virus—to educate themselves about who monkeypox affects, [how it spreads](https://time.com/6203173/monkeypox-spread-transmission/), and [what it feels like](https://time.com/6201191/what-monkeypox-feels-like/).

If you’ve ever watched _Queer Eye_ and “Yes, Queen”-ed along with me, I have an ask for you: put pressure on your state representatives and federal representatives to improve vaccine access. Let your legislators know that this is a priority for you as a voter.

It’s really sad to see in real time the way that people devalue issues they don’t think affect them. Everyone should care about monkeypox—because we should care about each other. That’s true despite what your own opinion on someone’s lifestyle might be.

And remember: right now it’s monkeypox, but there’s still HIV. There are still all these other diseases that people suffer from, and there’s so much stigma and so many barriers around access to care. This isn’t just a monkeypox story. This is a story of how we [consistently fail people on the margins](https://time.com/6174014/still-wearing-n95-mask/). We have to become bold about what we’re willing to witness—and no one should have been willing to witness this outbreak spread for the last two months.

```json
[{"@context":"https://schema.org","@type":"OpinionNewsArticle","@id":"https://time.com/6206159/jonathan-van-ness-monkeypox-response/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6206159/jonathan-van-ness-monkeypox-response/"},"headline":"Jonathan Van Ness: We Are Still Not Taking Monkeypox Seriously Enough","datePublished":"2022-08-15T15:18:09.000Z","dateModified":"2026-08-04T07:51:37.116Z","description":"Television personality Jonathan Van Ness argues that the U.S. monkeypox response has been shamefully inadequate.","url":"https://time.com/6206159/jonathan-van-ness-monkeypox-response/","keywords":["healthscienceclimate"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt206bba181413aba0/698a349a457a52de63d66b5f/211007_JONATHAN_VAN_NESS_S3_132_V1_R2.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Jonathan Van Ness","jobTitle":null,"url":"https://time.com/author/jonathan-van-ness/"}],"articleSection":"Ideas","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt206bba181413aba0/698a349a457a52de63d66b5f/211007_JONATHAN_VAN_NESS_S3_132_V1_R2.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"211007_JONATHAN_VAN_NESS_S3_132_V1_R2","caption":"Jonathan Van Ness","creditText":"Danielle Levitt","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/ideas/","name":"Ideas"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/6206159/jonathan-van-ness-monkeypox-response/","name":"Jonathan Van Ness: We Are Still Not Taking Monkeypox Seriously Enough"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"FDA Recommends New Monkeypox Vaccine Strategy to Stretch Supply","description":"On August 9, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new way of administering the Jynneos monkeypox vaccine. The move allows doctors to give patients smaller doses in order to get more shots out of each vial and protect more people quickly. It’s the latest step in the federal government’s response to the growing monkeypox outbreak, which it declared a public health emergency on August 4.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/WCNa2knN/poster.jpg?width=720","uploadDate":"2022-08-10T18:33:16.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/WCNa2knN.m3u8","embedUrl":"https://time.com/6206159/jonathan-van-ness-monkeypox-response/","duration":"PT3M47S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/6206159/jonathan-van-ness-monkeypox-response/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}]
```

